CompanyDrug

Yifan Pharmaceutical’s F-627 Receives NMPA Approval for Neutropenia Treatment in Cancer Patients

CompanyDrug

Jiangsu Nhwa Pharmaceutical Receives NMPA Approval for Olinvyk (Oliceridine) Injection

CompanyDrug

Innovent Biologics’ Tyvyt Secures NMPA Approval for EGFR-Mutated NSCLC Treatment

Policy / Regulatory

China’s NHC Releases Draft Guidelines for Somatic Cell Clinical Research, Seeks Public Input

CompanyDeals

Zion Pharma’s ZN-A-1041 Acquired by Roche for Global Development and Commercialization

CompanyDrug

Grand Pharmaceutical Group Files NDA for Ophthalmic Analgesic APP13007 with US FDA

CompanyDeals

Neuro3 Therapeutics Secures Exclusive License Deal with Lundbeck for KCNQ2 Activator Programs

Company

Organon Reports Q1 2023 Revenue Growth, Highlights Women’s Health and Biosimilars Progress

CompanyDrug

US FDA Nears Regulatory Decision on Junshi Biosciences’ PD-1 Inhibitor Tuoyi

CompanyDeals

Acorda Therapeutics Strikes Deal with Hangzhou Chance for Inbrija Distribution in China

CompanyDrug

RemeGen Ltd Receives Approval for Phase I Clinical Study of RC198 in Solid Tumors

CompanyDrug

Grand Pharmaceutical Group Completes Enrollment in Phase III Study for Ryaltris Nasal Spray